Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **microbial cell membrane and biofilm matrix** refers collectively to the structural and functional barriers that enclose microbial cells and surround communities embedded within biofilms. The cell membrane is the lipid bilayer that insulates the cell, while the biofilm matrix (often called extracellular polymeric substance, EPS) is a highly heterogeneous aggregation of secreted biopolymers, including polysaccharides, proteins, lipids, and extracellular DNA[1][3][6][7]. The matrix enables cell adhesion, community formation, and provides a three-dimensional scaffold that offers protection from environmental stresses—including antimicrobial agents and immune effectors—by acting as a physical barrier and modifying the local chemical environment[1][7]. Both structures play a crucial role in the persistence of chronic infections, enhanced resistance to eradication, and present major challenges for conventional anti-infective therapies[1][5]. While antimicrobials and specific agents can target either the membrane or matrix, their compositional diversity means that "microbial cell membranes and biofilm matrix" is not a single standardized target but rather a broad category encompassing many possible molecular targets[6][7]. Thus, while highly relevant as therapeutic targets, the term is non-specific and often captures an entire class of structural and functional barriers rather than a single molecule or protein. Notes on correctness: - The term **"microbial cell membranes and biofilm matrix" is overly broad** and not the name of a specific molecule, protein, or gene; it refers to two functionally distinct yet related structures[1][6][7]. - For structured databases or precise drug-target mapping, this entry is **too general**; it should be split into more specific entries (e.g., "Bacterial cell membrane", "Fungal cell membrane", "Biofilm extracellular matrix", or even individual matrix components such as "β-1,3-glucan", "curli", "alginate", etc.). - Entry is flagged as *is_incorrect: true* due to lack of specificity and canonical naming conventions.
Disruption of extracellular polymeric substances (enzymatic cleavage, chemical dispersal) Permeabilization of membrane integrity Inhibition of matrix formation (targeting polysaccharide or protein synthesis) Enhanced drug penetration through matrix modification Inhibition of quorum sensing pathways
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial cell membrane and biofilm matrix.